Related Experiment Video
Updated: Jun 22, 2025

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
When Medication Treatment for Opioid Use Disorder Gets Disrupted by Extra-Clinical Variables, How Should Clinicians
Taleed El-Sabawi1, Kelly Gillespie2
1Assistant professor of law at Florida International University College of Law in Miami.
Discrimination against patients in medication for opioid use disorder (MOUD) treatment is common. Clinicians can mitigate treatment disruptions from jail time by using practical strategies to ensure care continuity for MOUD patients.
Area of Science:
- Addiction Medicine
- Public Health
- Criminal Justice
Background:
- Structural and systemic discrimination significantly impacts individuals with substance use disorder.
- Patients receiving medication for opioid use disorder (MOUD) face treatment disruptions due to arrests and incarceration.
Purpose of the Study:
- To highlight the challenges in maintaining MOUD treatment continuity for patients encountering the justice system.
- To propose practical strategies for clinicians to mitigate treatment disruptions caused by incarceration.
Main Methods:
- This is a case commentary.
- It outlines practical approaches for clinicians to address treatment continuity for MOUD patients.
Main Results:
- Arrests and pretrial confinement can lead to significant disruptions in MOUD treatment.
- Clinician-led interventions can mitigate the harms associated with these treatment interruptions.
Conclusions:
- Continuity of care for MOUD patients is crucial and can be preserved despite justice system involvement.
- Proactive clinical strategies are essential to support patients with substance use disorder during periods of confinement.
Related Concept Videos
Drug Abuse and Addiction: Pharmacological Phenomena
Drug Therapy
Antianxiety Medications
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Drug Dependence
Psychosis: Goals of Pharmacotherapy
Factors Affecting Drug Response: Overview

